Immunovant, Inc. (IMVT)

Typically moves ±7.96% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Immunovant, Inc. (IMVT) has reported earnings 28 times since Dec 20, 2019. The stock moves an average of ±7.96% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +35.16% (May 20, 2026) and its largest decline was -37.99% (Jun 01, 2021). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How IMVT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.96%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	+1.25%	open_in_new
May 20, 2026	☀ PRE	+35.16%	open_in_new
Feb 06, 2026	☀ PRE	+12.43%	open_in_new
Nov 10, 2025	☀ PRE	+0.09%	open_in_new
Aug 11, 2025	☀ PRE	-4.53%	open_in_new
May 29, 2025	☀ PRE	+5.6%	open_in_new
Feb 06, 2025	☀ PRE	-9.55%	open_in_new
Nov 07, 2024	☀ PRE	-4.74%	open_in_new
Aug 06, 2024	☽ POST	-3.12%	open_in_new
May 29, 2024	☽ POST	-10.69%	open_in_new
Feb 12, 2024	☀ PRE	+3.35%	open_in_new
Nov 09, 2023	☀ PRE	-6.23%	open_in_new
Aug 10, 2023	☀ PRE	+6.69%	open_in_new
May 22, 2023	☀ PRE	+11.98%	open_in_new
Feb 03, 2023	☀ PRE	-2.95%	open_in_new
Nov 04, 2022	☀ PRE	+1.09%	open_in_new
Aug 05, 2022	☀ PRE	+8.68%	open_in_new
Jun 08, 2022	☀ PRE	-8.2%	open_in_new
Feb 04, 2022	☀ PRE	-1.83%	open_in_new
Nov 05, 2021	☀ PRE	-1.61%	open_in_new
Aug 09, 2021	☀ PRE	+0.39%	open_in_new
Jun 01, 2021	☀ PRE	-37.99%	open_in_new
Feb 16, 2021	☀ PRE	-27.19%	open_in_new
Nov 12, 2020	☀ PRE	+0.02%	open_in_new
Aug 12, 2020	☽ POST	+3.08%	open_in_new
Jun 29, 2020	☀ PRE	-7.01%	open_in_new
Feb 14, 2020	☀ PRE	+6.41%	open_in_new
Dec 20, 2019	☽ POST	-1.1%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.96%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 27 →

Funds holding

$828261473

Total value held

Buying

23 added · 3 reduced

Blackrock, Inc.

$276679973 +9.22%

State Street Corp

$177893203 +1.74%

Morgan Stanley

$174727164 +16.97%

Goldman Sachs Group Inc

$67473081 -1.90%

Bank Of America Corp /De/

$45521345 +32.20%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260903	open_in_new SEC.gov
4	20260828	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
4	20260724	open_in_new SEC.gov
4	20260724	open_in_new SEC.gov
4	20260724	open_in_new SEC.gov
ARS	20260722	open_in_new SEC.gov

Frequently asked about IMVT earnings

When does Immunovant, Inc. report earnings next? expand_more

Immunovant, Inc. (IMVT)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IMVT stock move after earnings? expand_more

Over 28 reports, IMVT has moved an average of ±7.96% the session after earnings, closing higher 50.0% of the time.

What was IMVT's biggest post-earnings move? expand_more

IMVT's largest post-earnings gain on record was +35.16% on May 20, 2026, and its largest decline was -37.99% on Jun 01, 2021.

Where can I find Immunovant, Inc.'s SEC filings? expand_more

All of Immunovant, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.